// startup autopsy
Biolipox
Lipid science without a commercial engine
marketfitAcqui-hire
Fatal mistake: Biolipox over-invested in platform science without securing late-stage clinical partners or licensing deals needed to justify standalone operations.
| Founded | 2000 |
|---|---|
| Closed | 2006 |
| Country | Sweden |
| Sector | Healthtech |
50%
50%
Key Events Timeline
FOUNDING
Biolipox founded in Sweden to develop lipid mediator therapeutics for inflammatory diseases.
FUNDING
Raised significant venture rounds totaling toward $41M to fund preclinical and early clinical research.
PRODUCT LAUNCH
Advanced lead compound into early clinical studies but struggled to attract major pharma partnership.
SHUTDOWN
Biolipox acquired and absorbed by a larger pharmaceutical entity, ceasing independent operations.